Financial giants have made a conspicuous bullish move on Baxter Intl. Our analysis of options history for Baxter Intl BAX revealed 8 unusual trades.
Delving into the details, we found 75% of traders were bullish, while 25% showed bearish tendencies. Out of all the trades we spotted, 5 were puts, with a value of $427,087, and 3 were calls, valued at $92,692.
Expected Price Movements
Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $27.5 to $38.0 for Baxter Intl over the last 3 months.
Volume & Open Interest Trends
Examining the volume and open interest provides crucial insights into stock research. This information is key in gauging liquidity and interest levels for Baxter Intl's options at certain strike prices. Below, we present a snapshot of the trends in volume and open interest for calls and puts across Baxter Intl's significant trades, within a strike price range of $27.5 to $38.0, over the past month.
Baxter Intl Option Volume And Open Interest Over Last 30 Days
Largest Options Trades Observed:
Symbol | PUT/CALL | Trade Type | Sentiment | Exp. Date | Ask | Bid | Price | Strike Price | Total Trade Price | Open Interest | Volume |
---|---|---|---|---|---|---|---|---|---|---|---|
BAX | PUT | TRADE | BULLISH | 06/07/24 | $0.6 | $0.25 | $0.3 | $34.00 | $216.7K | 0 | 5.0K |
BAX | PUT | SWEEP | BULLISH | 05/17/24 | $1.0 | $0.95 | $0.95 | $37.50 | $77.5K | 4.3K | 815 |
BAX | PUT | SWEEP | BEARISH | 01/17/25 | $2.4 | $1.6 | $2.4 | $35.00 | $60.0K | 837 | 0 |
BAX | PUT | SWEEP | BULLISH | 05/03/24 | $1.0 | $0.95 | $0.95 | $38.00 | $44.0K | 1.4K | 12 |
BAX | CALL | TRADE | BEARISH | 01/16/26 | $13.5 | $11.2 | $11.74 | $27.50 | $38.7K | 1 | 33 |
About Baxter Intl
Baxter offers a variety of medical instruments and supplies to caregivers. It enhanced its portfolio of hospital-focused offerings by acquiring Hillrom in late 2021, which added basic equipment, including hospital beds, to the portfolio, although about half of Hillrom's revenue comes from more digitally connected offerings like its smart beds and Voalte medical communications app. From its legacy operations, Baxter offers tools to help patients with acute and chronic kidney failure, which it plans to spin off by mid-2024. It also sells a variety of injectable therapies for use in care settings, such as IV pumps, administrative sets, and solutions; nutritional products; and surgical sealants and hemostatic agents.
Baxter Intl's Current Market Status
- With a trading volume of 5,765,066, the price of BAX is down by -8.39%, reaching $36.95.
- Current RSI values indicate that the stock is may be oversold.
- Next earnings report is scheduled for 0 days from now.
Professional Analyst Ratings for Baxter Intl
In the last month, 1 experts released ratings on this stock with an average target price of $44.0.
- Consistent in their evaluation, an analyst from Citigroup keeps a Neutral rating on Baxter Intl with a target price of $44.
Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest Baxter Intl options trades with real-time alerts from Benzinga Pro.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Date of Trade | ticker | Put/Call | Strike Price | DTE | Sentiment |
---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.